EverPoint Asset Management’s Eli Lilly LLY Stock Holding History

EverPoint Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.36M	Sell	100,000 -175,000	-64%	-$13M	0.14%	179
2016 Q3	$22.1M	Sell	275,000 -175,000	-39%	-$14M	0.4%	65
2016 Q2	$35.4M	Buy	450,000 +420,000	+1,400%	+$31.6M	0.7%	27
2016 Q1	$2.16M	Sell	30,000 -40,000	-57%	-$3.03M	0.04%	328
2015 Q4	$5.9M	Buy	+70,000	New	+$5.81M	0.12%	225
2015 Q2	–	Sell	-230,000	Closed	-$16.7M	–	527
2015 Q1	$16.7M	Sell	230,000 -160,000	-41%	-$11.4M	0.32%	92
2014 Q4	$26.9M	Buy	+390,000	New	+$26.3M	0.61%	33

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EverPoint Asset Management's LLY Position: Q4 2016 in Review

EverPoint Asset Management reduced its Eli Lilly (LLY) stake by 64% in Q4 2016, selling an estimated $13M and leaving 100,000 shares worth $7.36M. The position accounts for 0.14% of the portfolio, ranked #179.

EverPoint Asset Management first reported a position in LLY in Q4 2014 and has held it in 7 quarters since. The position peaked at $35.4M in Q2 2016. 1,213 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

EverPoint Asset Management held 100,000 shares of Eli Lilly worth $7.36M as of Q4 2016.
EverPoint Asset Management sold 175,000 Eli Lilly shares in Q4 2016, an estimated $13M.
Eli Lilly made up 0.14% of EverPoint Asset Management's portfolio in Q4 2016, its #179 holding.
EverPoint Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 7 quarters since.
EverPoint Asset Management's Eli Lilly position peaked at $35.4M in Q2 2016.
1,213 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.